Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Medexus Pharmaceuticals Inc (PDDPF)

Medexus Pharmaceuticals Inc (PDDPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade PDDPF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.3000 +40.00%
on 07/24/20
3.9100 -17.65%
on 07/23/20
+0.2327 (+7.79%)
since 07/17/20
3-Month
1.7000 +89.41%
on 06/05/20
3.9900 -19.30%
on 07/01/20
+1.3200 (+69.47%)
since 05/19/20
52-Week
1.7000 +89.41%
on 06/05/20
3.9900 -19.30%
on 07/01/20
-0.2187 (-6.36%)
since 07/12/19

Most Recent Stories

More News
Medexus Pharmaceuticals Reports Operating and Financial Results for the Three- and Six-Month Periods Ending September 30, 2020

Management to host conference call at 8:00 AM Eastern Time on Tuesday, November 17th, 2020

PDDPF : 3.2200 (unch)
MDP.VN : 7.750 (-4.91%)
MEDXF : 1.3000 (unch)
Medexus Reaches 50% Enrollment in IXINITY® Phase 4 Clinical Trial Targeting Label Expansion for Pediatric Hemophilia B Patients

TORONTO, CHICAGO and MONTREAL, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus” ) ( TSXV: MDP , OTCQ X : MEDXF ) today announced...

MDP.VN : 7.750 (-4.91%)
PDDPF : 3.2200 (unch)
MEDXF : 1.3000 (unch)
Medexus Pharmaceuticals Schedules Second Quarter Fiscal 2021 Conference Call

Conference call to be held at 8:00 AM Eastern Time on Tuesday, November 17th, 2020

PDDPF : 3.2200 (unch)
MDP.VN : 7.750 (-4.91%)
MEDXF : 1.3000 (unch)
Medexus Announces Engagement of Westmount Capital and Equity Incentive Grants to Insiders

TORONTO and CHICAGO and MONTREAL, Oct. 30, 2020 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “ Company ” or “ Medexus ”) (TSXV: MDP) (OTCQX: MEDXF)   (Frankfurt: P731) announced today...

PDDPF : 3.2200 (unch)
MDP.VN : 7.750 (-4.91%)
MEDXF : 1.3000 (unch)
Medexus Appoints Michael Pine as Senior Vice President of Business Development and Strategy

MONTREAL, Sept. 25, 2020 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP, OTCQ X : MEDXF ) , today announced the appointment of Michael Pine as...

MDP.VN : 7.750 (-4.91%)
PDDPF : 3.2200 (unch)
MEDXF : 1.3000 (unch)
Medexus Engages Adelaide Capital for Investor Relations Services and Reports Annual Meeting Results

TORONTO and CHICAGO and MONTREAL, Sept. 18, 2020 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “ Company ” or “Medexus ”) (TSXV: MDP) (OTCQX: MEDXF)   is pleased to announce that it...

PDDPF : 3.2200 (unch)
MDP.VN : 7.750 (-4.91%)
MEDXF : 1.3000 (unch)
Medexus Reports Health Canada Approval of Gleolan® (5-ALA) for Use in Guided Surgical Resection of High-Grade Gliomas

TORONTO and CHICAGO and MONTREAL, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc.  (the “Company” or “Medexus”) (TSXV: MDP, OTCQX: MEDXF) today announces that on September...

MDP.VN : 7.750 (-4.91%)
PDDPF : 3.2200 (unch)
MEDXF : 1.3000 (unch)
Medexus Announces Move to a Virtual Meeting for 2020 AGM and Equity Incentive Grants

TORONTO and CHICAGO and MONTREAL, Aug. 24, 2020 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (the “Company” or “Medexus”) (TSXV: MDP, OTCQX: PDDPF) today announced that due to public health...

MDP.VN : 7.750 (-4.91%)
PDDPF : 3.2200 (unch)
MEDXF : 1.3000 (unch)
Medexus Reports Triamcinolone Hexacetonide Injectable Suspension Approved for Inclusion on Quebec’s RAMQ List of Medications (Basic Plan and Institutions)

MONTREAL, Aug. 24, 2020 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc.  (the “Company” or “Medexus”) (TSXV: MDP, OTCQX: MEDXF) is pleased to announce that Triamcinolone Hexacetonide Injectable...

MDP.VN : 7.750 (-4.91%)
PDDPF : 3.2200 (unch)
MEDXF : 1.3000 (unch)
Medexus Announces New U.S. Ticker “MEDXF” on the OTCQX

Medexus will continue to trade on the TSX Venture under ticker “MDP”

MDP.VN : 7.750 (-4.91%)
PDDPF : 3.2200 (unch)
MEDXF : 1.3000 (unch)

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 3.2801
1st Resistance Point 3.2501
Last Price 3.2200
1st Support Level 3.1750
2nd Support Level 3.1299
3rd Support Level N/A

See More

52-Week High 3.9900
Last Price 3.2200
Fibonacci 61.8% 3.1152
Fibonacci 50% 2.8450
Fibonacci 38.2% 2.5748
52-Week Low 1.7000

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar